BILIARY TRACT CANCER

This study tested a combination of three drugs (mFOLFOX6, bevacizumab, and atezolizumab) in 20 patients with advanced bile duct cancer who had already tried one prior treatment. The goal was to see if this mix could shrink tumors or control the disease. The drugs were given every…

This study looked at side effects of the drug IMFINZI when given together with standard chemotherapy (gemcitabine and cisplatin) to people with advanced bile duct cancer that cannot be removed by surgery. A total of 236 patients took part. The main goal was to track any unwanted …

This study tested a combination of three drugs (capecitabine, lenvatinib, and tislelizumab) given after surgery to 65 adults with biliary tract cancer. The goal was to see if this treatment could help keep cancer from coming back and improve survival. The study is complete, and r…

This study tested two different chemotherapy combinations in 93 people with advanced bile duct cancer that could not be removed by surgery. The goal was to see which combination worked better at slowing cancer growth. Participants received either nal-IRI with 5-FU and leucovorin,…

This study tested a mix of immunotherapy (nivolumab) and chemotherapy drugs in 34 people with advanced bile duct cancer that had gotten worse after initial treatment. The goal was to see if the combination could shrink tumors or slow the cancer's growth. The approach aims to cont…

This study tested the drug nivolumab in 54 people with advanced bile duct or gallbladder cancer that had stopped responding to other treatments. Nivolumab is an immunotherapy that helps the immune system attack cancer cells. The main goal was to see if the drug could shrink tumor…

This study looked at how well the drug T-DXd works compared to usual treatments for people with several types of advanced cancers that have high levels of a protein called HER2. Researchers used existing data from earlier trials and real-world medical records to compare outcomes.…

This study reviewed medical records of 729 people in Japan with biliary tract cancer who received standard cancer therapy. Researchers wanted to see if bile duct complications (like blockages or infections) that required hospital care affected how long patients could stay on trea…

This study created a registry of 159 adults with biliary tract cancers, including gallbladder and bile duct cancers. Researchers collected information on treatments, quality of life, and medical history to better understand these rare cancers. The goal was to build a foundation f…

This study looked at whether two easy-to-use frailty questionnaires (G8 and VES-13) can predict serious side effects from chemotherapy in people 65 and older with gastrointestinal cancers. Researchers followed 72 patients before, during, and after treatment to see if frailty scor…